日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Role of Antidrug Antibodies in Oncolytic Viral Therapy: A Dynamic Modelling Approach in Cancer Patients Treated with V937 Alone or in Combination

抗药抗体在溶瘤病毒疗法中的作用:采用动态建模方法研究接受V937单药或联合治疗的癌症患者

Parra-Guillen, Zinnia P; Trocóniz, Iñaki F; Freshwater, Tomoko

Weight-Based Pembrolizumab Dosing at 4 mg/kg Every 6 Weeks Leads to Exposures Below Approved Doses with Unestablished Efficacy: A Pharmacokinetic Model-Based Simulation Analysis

基于体重的帕博利珠单抗给药方案(4 mg/kg,每 6 周一次)会导致药物暴露量低于批准剂量,且疗效尚未确定:一项基于药代动力学模型的模拟分析

Lala, Mallika; Bardia, Aditya; Calles, Antonio; Danesi, Romano; Freshwater, Tomoko; Healy, Jane A; Herbst, Roy S

Matters Arising: on the willingness to trade-off years of life for an HIV cure

引发讨论的问题:人们是否愿意为了治愈艾滋病而牺牲寿命

Dubé, Karine; Taylor, Jeff; Freshwater, William; Villa, Thomas J; Palm, David; Mapp, Derrick; Dee, Lynda

"A cure might help, but it won't erase it all": a qualitative study of policy challenges and priorities for long-term survivors of HIV in the United States

“治愈或许有所帮助,但无法彻底消除所有问题”:一项关于美国艾滋病长期幸存者政策挑战和优先事项的定性研究

Ahmed, Ali; Taylor, Jeff; Lau, Rachel; Lai, Joyce Ching-Jung; Deshan Diunugala, Sithara; Louella, Michael; Villa, Thomas J; Freshwater, William; Averitt, Dawn; Karris, Maile; Berry, Jeff; Dee, Lynda; Dubé, Karine

Development and validation of a controlled heating apparatus for long-term MRI of 3D microfluidic tumor models

开发和验证用于三维微流控肿瘤模型长期磁共振成像的可控加热装置

Alkhadrawi, Hassan; Dese, Kokeb; Panchal, Dhruvi M; Pueschel, Alexander R; Freshwater, Kasey A; Stewart, Amanda; Henderson, Haleigh; Elkins, Michael; Dave, Raj T; Wilson, Hunter; Bennewitz, John W; Bennewitz, Margaret F

Chinook salmon depth distributions on the continental shelf are shaped by interactions between location, season, and individual condition

大陆架上奇努克鲑鱼的深度分布受地点、季节和个体状况等因素相互作用的影响。

Freshwater, Cameron; Anderson, Sean C; Huff, David D; Smith, Joseph M; Jackson, Doug; Hendriks, Brian; Hinch, Scott G; Johnston, Stephen; Trites, Andrew W; King, Jackie

A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors

MEK抑制剂selumetinib联合pembrolizumab治疗晚期或转移性实体瘤的1期临床试验

Chénard-Poirier, Maxime; Hansen, Aaron R; Gutierrez, Martin E; Rasco, Drew; Xing, Yan; Chen, Lin-Chi; Zhou, Heng; Webber, Andrea L; Freshwater, Tomoko; Sharma, Manish R

Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial

更正:CXCR2拮抗剂navarixin联合pembrolizumab治疗特定晚期实体瘤:一项II期随机试验

Armstrong, Andrew J; Geva, Ravit; Chung, Hyun Cheol; Lemech, Charlotte; Miller, Wilson H Jr; Hansen, Aaron R; Lee, Jong-Seok; Tsai, Frank; Solomon, Benjamin J; Kim, Tae Min; Rolfo, Christian; Giranda, Vincent; Ren, Yixin; Liu, Fang; Kandala, Bhargava; Freshwater, Tomoko; Wang, Judy S

CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial

CXCR2拮抗剂navarixin联合pembrolizumab治疗特定晚期实体瘤:一项II期随机试验

Armstrong, Andrew J; Geva, Ravit; Chung, Hyun Cheol; Lemech, Charlotte; Miller, Wilson H Jr; Hansen, Aaron R; Lee, Jong-Seok; Tsai, Frank; Solomon, Benjamin J; Kim, Tae Min; Rolfo, Christian; Giranda, Vincent; Ren, Yixin; Liu, Fang; Kandala, Bhargava; Freshwater, Tomoko; Wang, Judy S

Partner protections in HIV cure-related trials involving analytical treatment interruption: Updated toolkit to mitigate HIV transmission risk

在涉及分析性治疗中断的艾滋病治愈相关试验中,伴侣保护措施:更新后的工具包,以降低艾滋病毒传播风险

Dubé, Karine; Villa, Thomas J; Freshwater, William; Mauk, Brittney; Rid, Annette; Peluso, Michael J